Share Twitter LinkedIn Facebook Email Joseph Alvarnas, MD @cityofhope Vice President of Government Affairs, Senior Medical Director for Employer Strategy, Director of Value Based Analytics, City of Hope explains his philosophy regarding CAR-T cell therapy value to the care of patients.
Cell Therapy for Solid Tumors: Immunotherapy Biomarkers Anusha Kalbasi, MD MOASC [2023] Immunotherapy 2 Mins Read
O-RECIST, iRECIST, ImmunoPET: Assessing Treatment Response – Anna M. Wu, MD – MOASC [2023] Immunotherapy 1 Min Read